Nobel winner died on eve of award
Monday 03 October 2011
A scientist awarded the Nobel Prize in medicine today for his discoveries about the immune system died three days ago without ever knowing of the honour.
The Nobel committee had not known of Ralph Steinman's death and it was unclear whether the prize would be rescinded because Nobel statutes do not allow posthumous awards.
Canadian Steinman, 68, who shared the prize with American Bruce Beutler and French scientist Jules Hoffmann, died on September 30 of pancreatic cancer, said Rockefeller University, adding he had been treated with immunotherapy based on his discovery of dendritic cells two decades earlier.
The cells help regulate adaptive immunity, an immune system response that purges invading micro-organisms from the body.
Nobel committee member Goran Hansson said the Nobel committee did not know Steinman was dead when it chose him as a winner and was looking through its regulations.
"It is incredibly sad news," Mr Hansson said. "We can only regret that he didn't have the chance to receive the news he had won the Nobel Prize. Our thoughts are now with his family."
The trio's discoveries have enabled the development of improved vaccines against infectious diseases. In the long term they could also yield better treatments of cancer, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and chronic inflammatory diseases.
Beutler and Hoffmann were cited for their discoveries in the 1990s of receptor proteins that can recognise bacteria and other microorganisms as they enter the body, and activate the first line of defence in the immune system, known as innate immunity.
The discoveries have helped scientists understand why the immune system sometimes attacks its own tissues, paving the way for new ways to fight inflammatory diseases, Hansson said.
"They have made possible the development of new methods for preventing and treating disease, for instance with improved vaccines against infections and in attempts to stimulate the immune system to attack tumours the committee said.
No vaccines are on the market yet, but Hansson told AP that vaccines against hepatitis are in the pipeline. "Large clinical trials are being done today," he said.
- 1 If you're not already angry about the migrant crisis, here's a history lesson to remind you why you really should be
- 2 David De Gea: Manchester United goalkeeper's £29m move to Real Madrid off - because paperwork 'not done in time'
- 3 Pansexual: What is it - and when did the term gain popularity?
- 4 A Chinese journalist has appeared on state television 'confessing' to causing the stock market chaos
- 5 Blood Moon and Supermoon: September to bring brightest – and dimmest – full Moon of the year on same night
Miley Cyrus calls out hypocrisy of women’s nipples being taboo
The man who sold Minecraft to Microsoft for £2.5 billion says it's made him miserable
Nazi 'gold train': Fire engulfs suspected location of vehicle in Poland
Blood Moon and Supermoon: September to bring brightest – and dimmest – full Moon of the year on same night
Isis releases graphic video showing four Shia 'spies' being burned alive in Anbar, Iraq
Climate change: 2015 will be the hottest year on record 'by a mile', experts say
Jeremy Corbyn calls Osama bin Laden's killing a 'tragedy' - but was it taken out of context?
Tony Blair attacks Jeremy Corbyn's 'Alice In Wonderland' politics
Theresa May says migrants should be banned from entering the UK unless they have jobs lined up
Iain Duncan Smith 'should resign over disability benefit death figures', says Jeremy Corbyn
UN investigating British Government over human rights abuses caused by IDS welfare reforms
£28000 - £35000 per annum: Recruitment Genius: Experienced Electrician require...
£20000 - £22000 per annum: Recruitment Genius: This UK based B2C multi-channel...
Negotiable: Recruitment Genius: This company has a fantastic opportunity for a...
£60000 - £150000 per annum: Recruitment Genius: They are the go-to company for...